Cover Image
市場調查報告書

癲癇:全球臨床實驗檢討

Seizures Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 309559
出版日期 內容資訊 英文 112 Pages
訂單完成後即時交付
價格
Back to Top
癲癇:全球臨床實驗檢討 Seizures Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月28日 內容資訊: 英文 112 Pages
簡介

本報告提供癲癇相關的臨床研究最新趨勢分析,彙整疾病·治療方法概要,及主要已開發國家·新興國家的臨床實驗狀況,各地區、各階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊,為您概述為以下內容。

目錄

簡介

  • 癲癇
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲前五名國家的臨床實驗數量
    • 中南美前五名國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統(CNS)疾病整體比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:中樞神經系統(CNS)疾病整體比例

E7各國臨床實驗數量:Phase別

E7各國臨床實驗數量:各進展狀況

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

臨床實驗的目標的成就情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

  • 參加癲癇治療藥臨床實驗的前幾名企業

有潛力的藥劑

近幾年主要的臨床實驗的動向·成果(全2件)

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • UCB S.A.
    • Pfizer Inc.
    • Eisai
    • Novartis AG
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • Bial - Portela & Ca, S.A.
    • SK Holdings Co., Ltd.
    • H. Lundbeck A/S
    • Boehringer Ingelheim Auslandsbeteiligungs GmbH
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Institute of Neurological Disorders and Stroke
    • Assistance Publique - Hopitaux de Paris
    • All India Institute of Medical Sciences
    • Cincinnati Children's Hospital Medical Center
    • University of California, San Diego
    • Emory University
    • Yonsei University
    • Medical University of South Carolina
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Shiraz University of Medical Sciences

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2271CTIDB

GlobalData's clinical trial report, "Seizures Global Clinical Trials Review, H2, 2014" provides data on the Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Seizures
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Seizures to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Seizures to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Seizures
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Seizures Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Seizures
    • Jun 17, 2014: Qudexy XR (Topiramate) Extended-Release Capsules Phase 3 Data Published In Epilepsia
    • Jun 16, 2014: Eisai Announces Phase III Trial with Antiepileptic Drug Perampanel Meets Primary Endpoint as Adjunctive Therapy in Patients with Uncontrolled Primary Generalized Tonic-Clonic Seizures
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • UCB S.A.
      • Clinical Trial Overview of UCB S.A.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Bial - Portela & Ca, S.A.
      • Clinical Trial Overview of Bial - Portela & Ca, S.A.
      • SK Holdings Co., Ltd.
      • Clinical Trial Overview of SK Holdings Co., Ltd.
      • H. Lundbeck A/S
      • Clinical Trial Overview of H. Lundbeck A/S
      • Boehringer Ingelheim Auslandsbeteiligungs GmbH
      • Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Cincinnati Children's Hospital Medical Center
      • Clinical Trial Overview of Cincinnati Children's Hospital Medical Center
      • University of California, San Diego
      • Clinical Trial Overview of University of California, San Diego
      • Emory University
      • Clinical Trial Overview of Emory University
      • Yonsei University
      • Clinical Trial Overview of Yonsei University
      • Medical University of South Carolina
      • Clinical Trial Overview of Medical University of South Carolina
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Seizures Therapeutics, Global, Clinical Trials by Region, 2014*
  • Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Seizures Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Seizures Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Seizures Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Seizures Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Seizures Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Bial - Portela & Ca, S.A., 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Holdings Co., Ltd., 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014*

List of Figures

  • Seizures Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Seizures Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Seizures Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Seizures Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Seizures Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Seizures Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top